Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Single Centre Open Label Trial to Investigate the Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta (NeoRecormon®) in Healthy Japanese and Caucasian Male Subjects

NCT01085552 is registered in ClinicalTrials.gov with InCROM Europe Clinical Research as lead sponsor.

NCT NCT01085552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01085552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Single Centre Open Label Trial to Investigate the Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta (NeoRecormon®) in Healthy Japanese and Caucasian Male Subjects
Lead sponsor
InCROM Europe Clinical Research
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2007
Completion date
October 31, 2008
Enrollment
23 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anaemia, chronic kidney failure